Literature DB >> 16450347

Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients.

Tanja Schmitz-Hübsch1, Sophie Tezenas du Montcel, Laszlo Baliko, Sylvia Boesch, Sara Bonato, Roberto Fancellu, Paola Giunti, Christoph Globas, Jun-Suk Kang, Berry Kremer, Caterina Mariotti, Bela Melegh, Maryla Rakowicz, Rafal Rola, Sylvie Romano, Lodger Schöls, Sandra Szymanski, Bart P C van de Warrenburg, Elzbieta Zdzienicka, Alexandra Dürr, Thomas Klockgether.   

Abstract

To evaluate the efficacy of treatments in spinocerebellar ataxias (SCAs), appropriate clinical scales are required. This study evaluated metric properties of the International Cooperative Ataxia Rating Scale (ICARS) in 156 SCA patients and 8 controls. ICARS was found to be a reliable scale satisfying accepted criteria for interrater reliability, test-retest reliability, and internal consistency. Although validity testing was limited, we found evidence of validity of ICARS when ataxia disease stages and Barthel index were used as external criteria. On the other hand, our study revealed two major problems associated with the use of ICARS. First, the redundant and overlapping nature of several items gave rise to a considerable number of contradictory ratings. Second, a factorial analysis showed that the rating results were determined by four different factors that did not coincide with the ICARS subscales, thus questioning the justification of ICARS subscore analysis in clinical trials. Copyright (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16450347     DOI: 10.1002/mds.20781

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  34 in total

1.  Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.

Authors:  Jeremy D Schmahmann; Raquel Gardner; Jason MacMore; Mark G Vangel
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

2.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Developing a smartphone application, triaxial accelerometer-based, to quantify static and dynamic balance deficits in patients with cerebellar ataxias.

Authors:  Giuseppe Arcuria; Christian Marcotulli; Raffaele Amuso; Giuliano Dattilo; Claudio Galasso; Francesco Pierelli; Carlo Casali
Journal:  J Neurol       Date:  2019-11-11       Impact factor: 4.849

4.  Longitudinal tracking of gait and balance impairments in cerebellar disease.

Authors:  Susanne M Morton; Ya-Weng Tseng; Kathleen M Zackowski; Jaclyn R Daline; Amy J Bastian
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

5.  The interrelationship between disease severity, dynamic stability, and falls in cerebellar ataxia.

Authors:  Roman Schniepp; Cornelia Schlick; Cauchy Pradhan; Marianne Dieterich; Thomas Brandt; Klaus Jahn; Max Wuehr
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

6.  A toolbox to visually explore cerebellar shape changes in cerebellar disease and dysfunction.

Authors:  S Mazdak Abulnaga; Zhen Yang; Aaron Carass; Kalyani Kansal; Bruno M Jedynak; Chiadi U Onyike; Sarah H Ying; Jerry L Prince
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-24

Review 7.  Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.

Authors:  Jonas Alex Morales Saute; Karina Carvalho Donis; Carmen Serrano-Munuera; David Genis; Luís Torres Ramirez; Pilar Mazzetti; Luis Velázquez Pérez; Pilar Latorre; Jorge Sequeiros; Antoni Matilla-Dueñas; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

8.  The effects of sleep dysfunction on cognition, affect, and quality of life in individuals with cerebellar ataxia.

Authors:  Akshata Sonni; Lauri B F Kurdziel; Bengi Baran; Rebecca M C Spencer
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

9.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

10.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.